» Articles » PMID: 28698726

Clinical and Epidemiological Aspects of Multiple Sclerosis in Children

Overview
Specialty Pediatrics
Date 2017 Jul 13
PMID 28698726
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Overall, 2%-5% of patients with multiple sclerosis (MS) experienced the first episode of disease before the age 18 years old. Since the age of onset among children is not similar to that in general population, clinicians often fail to early diagnose the disease. This study aimed to determine the epidemiological and clinical patterns of MS among Iranian children.

Materials & Methods: In this cross-sectional study carried out in Iran in 2014-2015, information was collected using a checklist with approved reliability and validity. Method sampling was consensus. Data were analyzed using frequency, mean and standard deviation indices by means of SPSS ver. 20 software.

Results: Totally, 177 MS children were investigated. 75.7% of them were female. Mean (SD), minimum and maximum age of subjects were 15.9 (2), 7 and 18 yr, respectively. The most reported symptoms were sensory (28.2%), motor (29.4%), diplopia (20.3%) and visual (32.8%). Primary MRI results showed 91.5% and 53.1% periventricular and spinal cord lesions, respectively.

Conclusion: MS is significantly more common among women. The most common age of onset is during the second decades. Sensory and motor problems are the most symptoms, while, periventricular and spinal cord lesions are the most MRI results.

Citing Articles

Clinical and Epidemiological Findings of Pediatric Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-based Study.

Nasiri E, Naseri A, Talebi M Iran J Child Neurol. 2023; 17(3):109-119.

PMID: 37637785 PMC: 10448846. DOI: 10.22037/ijcn.v17i2.34417.


Clinical and MRI characteristics of multiple sclerosis in Iranian Children and Adolescents.

Nasehi M, Nikkhah A, Saket S, Rezakhani S, Hosseini M, Zahed G Iran J Child Neurol. 2023; 17(1):91-98.

PMID: 36721833 PMC: 9881826. DOI: 10.22037/ijcn.v17i1.37363.


Multiple Sclerosis and MEN2 Neoplasia in a Female Patient: A Unique Co-Existence with Expanded Immunological Interest and Therapeutical Challenges, before and after Patient's COVID-19 Infection.

Markoglou N, Simeakis G, Alevizaki M, Velonakis G, Chatzistamatiou T, Spyropoulou-Vlachou M Biomedicines. 2022; 10(11).

PMID: 36359367 PMC: 9687925. DOI: 10.3390/biomedicines10112850.


Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis.

Moosazadeh M, Esmaeili R, Nasehi M, Abedi G, Afshari M, Farshidi F Iran J Neurol. 2017; 16(2):90-95.

PMID: 28761631 PMC: 5526783.

References
1.
Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, Dubois B . Natural history of multiple sclerosis with childhood onset. N Engl J Med. 2007; 356(25):2603-13. DOI: 10.1056/NEJMoa067597. View

2.
Ness J, Chabas D, Sadovnick A, Pohl D, Banwell B, Weinstock-Guttman B . Clinical features of children and adolescents with multiple sclerosis. Neurology. 2007; 68(16 Suppl 2):S37-45. DOI: 10.1212/01.wnl.0000259447.77476.a9. View

3.
Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M . Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol. 2007; 6(10):887-902. DOI: 10.1016/S1474-4422(07)70242-9. View

4.
Ascherio A, Munger K . Epidemiology of multiple sclerosis: from risk factors to prevention. Semin Neurol. 2008; 28(1):17-28. DOI: 10.1055/s-2007-1019126. View

5.
Noseworthy J, Lucchinetti C, Rodriguez M, Weinshenker B . Multiple sclerosis. N Engl J Med. 2000; 343(13):938-52. DOI: 10.1056/NEJM200009283431307. View